Concepedia

Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes

Vivian Fonseca, Anja Schweizer, Diego Albrecht, Michelle A. Baron, In-Youb Chang, S. Dejager

Diabetologia · 2007 · 370 citations · 14 references

DOIFull text

Open access

Concepts

References

14

Inhibition of Dipeptidyl Peptidase-4 Reduces Glycemia, Sustains Insulin Levels, and Reduces Glucagon Levels in Type 2 Diabetes

Bo Åhrén, Mona Landin‐Olsson, Per‐Anders Jansson et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 713 citations

, , +17

Twelve- and 52-Week Efficacy of the Dipeptidyl Peptidase IV Inhibitor LAF237 in Metformin-Treated Patients With Type 2 Diabetes

Bo Åhrén, Ramón Gomis, Eberhard Standl et al. · Diabetes Care · 2004 · 488 citations · Full text

, , +17

Mechanisms of the Age-Associated Deterioration in Glucose Tolerance

Rita Basu, Elena Breda, Ann L. Oberg et al. · Diabetes · 2003 · 437 citations · Full text

, , +17

Vildagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Model-Assessed β-Cell Function in Patients with Type 2 Diabetes

Andrea Mari, William M. Sallas, Yanling He et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 362 citations · Full text

, , +17

A Randomized Trial of Rosiglitazone Therapy in Patients With Inadequately Controlled Insulin-Treated Type 2 Diabetes

Philip Raskin, Marc Rendell, Matthew C. Riddle et al. · Diabetes Care · 2001 · 346 citations · Full text

, , +13